Shanghai Rendu Biotechnology Co., Ltd.

Equities

688193

CNE1000059K5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 23:00:00 09/05/2024 BST 5-day change 1st Jan Change
33.41 CNY -2.08% Intraday chart for Shanghai Rendu Biotechnology Co., Ltd. +5.90% -25.95%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai Rendu Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Shanghai Rendu Biotechnology Co., Ltd. authorizes a Buyback Plan. CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Rendu Biotechnology Gets Certificate for Registration of HIV Kit MT
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange Composite Index CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange A Share Index CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Coland Holdings Limited cancelled the acquisition of an unknown stake in Shanghai Rendu Biotechnology Co., Ltd. CI
Coland Holdings Limited agreed to acquire an unknown stake in Shanghai Rendu Biotechnology Co., Ltd. for TWD 180 million. CI
Chart Shanghai Rendu Biotechnology Co., Ltd.
More charts
Shanghai Rendu Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and sales of molecular diagnostic reagents. The Company utilizes ribonucleic acid (RNA) isothermal amplification technology to provides multiple series of diagnostic reagents, including respiration series, reproduction series, enterovirus series, blood-borne diseases series and other diagnostic reagents. The Company also designs and manufactures medical instruments. The Company mainly sells its products within domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 688193 Stock
  4. News Shanghai Rendu Biotechnology Co., Ltd.
  5. Shanghai Rendu Biotechnology Gets Certificate for Registration of HIV Kit